Nirupama Naidu

Risk stratification in early-stage estrogen receptor+/HER2-breast cancer patients: Comparative analysis of cost-effective methods

Charusheila Ramkumar, Chetana Basavaraj, M. Bakre, 2018 .

Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients

D. Doval, Charusheila Ramkumar, Chetana Basavaraj, 2019, Cancer medicine.

Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study on An Indian Cohort

Charusheila Ramkumar, Chetana Basavaraj, M. Bakre, 2017 .

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients

Charusheila Ramkumar, Chetana Basavaraj, L. Buturovic, 2019, BMC Cancer.

1675PRisk of recurrence prediction and optimum treatment planning for early stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia

Choudhary Shyam Prakash, Charusheila Ramkumar, Chetana Basavaraj, 2017 .

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients

Charusheila Ramkumar, Chetana Basavaraj, L. Buturovic, 2019, BMC Cancer.